Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $260.05 million. The enterprise value is $268.92 million.
| Market Cap | 260.05M |
| Enterprise Value | 268.92M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 8.63 million shares outstanding. The number of shares has increased by 3.01% in one year.
| Shares Outstanding | 8.63M |
| Shares Change (YoY) | +3.01% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 60.46% |
| Owned by Institutions (%) | 8.36% |
| Float | 3.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.82 |
| Forward PS | 4.34 |
| PB Ratio | 6.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.95 |
| EV / EBITDA | 1,210.56 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.35 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 52.67 |
| Debt / FCF | n/a |
| Interest Coverage | -5.58 |
Financial Efficiency
Return on equity (ROE) is -11.30% and return on invested capital (ROIC) is -13.81%.
| Return on Equity (ROE) | -11.30% |
| Return on Assets (ROA) | -7.00% |
| Return on Capital (ROIC) | -13.81% |
| Revenue Per Employee | $629,672 |
| Profits Per Employee | -$45,273 |
| Employee Count | 108 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 1.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.61% in the last 52 weeks. The beta is 1.59, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -27.61% |
| 50-Day Moving Average | 29.72 |
| 200-Day Moving Average | 33.25 |
| Relative Strength Index (RSI) | 53.80 |
| Average Volume (20 Days) | 25,172 |
Short Selling Information
The latest short interest is 170,464, so 1.98% of the outstanding shares have been sold short.
| Short Interest | 170,464 |
| Short Previous Month | 160,811 |
| Short % of Shares Out | 1.98% |
| Short % of Float | 4.98% |
| Short Ratio (days to cover) | 7.58 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $68.00 million and -$4.89 million in losses. Loss per share was -$0.59.
| Revenue | 68.00M |
| Gross Profit | 60.39M |
| Operating Income | -7.59M |
| Pretax Income | -4.89M |
| Net Income | -4.89M |
| EBITDA | 222,147 |
| EBIT | -4.15M |
| Loss Per Share | -$0.59 |
Balance Sheet
The company has $2.83 million in cash and $11.70 million in debt, giving a net cash position of -$8.87 million or -$1.03 per share.
| Cash & Cash Equivalents | 2.83M |
| Total Debt | 11.70M |
| Net Cash | -8.87M |
| Net Cash Per Share | -$1.03 |
| Equity (Book Value) | 43.29M |
| Book Value Per Share | 5.02 |
| Working Capital | 4.44M |
Cash Flow
In the last 12 months, operating cash flow was -$3.10 million and capital expenditures -$303,359, giving a free cash flow of -$3.40 million.
| Operating Cash Flow | -3.10M |
| Capital Expenditures | -303,359 |
| Free Cash Flow | -3.40M |
| FCF Per Share | -$0.40 |
Margins
Gross margin is 88.80%, with operating and profit margins of -11.17% and -7.19%.
| Gross Margin | 88.80% |
| Operating Margin | -11.17% |
| Pretax Margin | -7.19% |
| Profit Margin | -7.19% |
| EBITDA Margin | 0.33% |
| EBIT Margin | -6.10% |
| FCF Margin | -5.00% |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.01% |
| Shareholder Yield | -3.01% |
| Earnings Yield | -1.88% |
| FCF Yield | -1.31% |
Analyst Forecast
The average price target for Sanara MedTech is $51.50, which is 70.81% higher than the current price. The consensus rating is "Buy".
| Price Target | $51.50 |
| Price Target Difference | 70.81% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Sanara MedTech has an Altman Z-Score of 5.84 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.84 |
| Piotroski F-Score | 3 |